Joseph A DiMasi (Joseph DiMasi)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Health Insurance

Top Venues

Clinical and translational science

Therapeutic innovation & regulatory science

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph A DiMasi, Abigail Dirks, Zachary Smith, Sarah Valentine, Jennifer C Goldsack, Thomas Metcalfe, Upinder Grewal, Lada Leyens, Ute Conradi, Daniel R Karlin, Lesley Maloney, Kenneth A Getz, Bert Hartog
Assessing the net financial benefits of employing digital endpoints in clinical trials. Clinical and translational science 17 (8) (2024)
Joseph A DiMasi, Abigail Dirks, Zachary Smith, Sarah Valentine, Jennifer C Goldsack, Thomas Metcalfe, Upinder Grewal, Lada Leyens, Ute Conradi, Daniel R Karlin, Lesley Maloney, Kenneth A Getz, Bert Hartog
Assessing the net financial benefits of employing digital endpoints in clinical trials. Clinical and translational science 17 (8) (2024)
Joseph A DiMasi, Zachary Smith, Ingrid Oakley-Girvan, Andrew Mackinnon, Mary Costello, Pamela Tenaerts, Kenneth A Getz
Assessing the Financial Value of Decentralized Clinical Trials. Therapeutic innovation & regulatory science (2022)
Tal Burt, Ad F Roffel, Oliver Langer, Kirsten Anderson, Joseph A DiMasi
Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity? Clinical and translational science 15 (6) (2022)
Joseph A DiMasi, Michael Wilkinson
The Financial Benefits of Faster Development Times: Integrated Formulation Development, Real-Time Manufacturing, and Clinical Testing. Therapeutic innovation & regulatory science 54 (6) (2020)